These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 35027053)
1. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma. Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells. Che G; Gao H; Tian J; Hu Q; Xie H; Zhang Y Pediatr Dev Pathol; 2020; 23(2):144-151. PubMed ID: 31498707 [TBL] [Abstract][Full Text] [Related]
3. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. Lu X; Li G; Liu S; Wang H; Chen B J Ovarian Res; 2021 Jul; 14(1):90. PubMed ID: 34238324 [TBL] [Abstract][Full Text] [Related]
4. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis. Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360 [TBL] [Abstract][Full Text] [Related]
5. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells. Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999 [TBL] [Abstract][Full Text] [Related]
6. MiR-135b improves proliferation and regulates chemotherapy resistance in ovarian cancer. Wang J; Zhang R; Zhang B; Zhang L; Jiang W; Liu X; Duan X J Mol Histol; 2022 Aug; 53(4):699-712. PubMed ID: 35793009 [TBL] [Abstract][Full Text] [Related]
7. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner. Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
9. CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3. Li B; Zhang L J Ovarian Res; 2021 Nov; 14(1):160. PubMed ID: 34789310 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN. Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950 [TBL] [Abstract][Full Text] [Related]
11. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A. Wang J; Liu L J Ovarian Res; 2021 Nov; 14(1):165. PubMed ID: 34798882 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene. Jian B; Li Z; Xiao D; He G; Bai L; Yang Q Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960 [TBL] [Abstract][Full Text] [Related]
13. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B. Niu Q; Liu Z; Gao J; Wang Q Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma. Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. Sun B; Hu N; Cong D; Chen K; Li J Bioengineered; 2021 Dec; 12(1):3219-3228. PubMed ID: 34266345 [TBL] [Abstract][Full Text] [Related]
16. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo. Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells. Huang S; Li X; Zhu H Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403 [TBL] [Abstract][Full Text] [Related]
18. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway. Lu C; Wang H; Chen S; Yang R; Li H; Zhang G J Cell Mol Med; 2018 Apr; 22(4):2478-2487. PubMed ID: 29392841 [TBL] [Abstract][Full Text] [Related]
19. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN. Song L; Chen L; Luan Q; Kong Q J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525 [TBL] [Abstract][Full Text] [Related]
20. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma. Wang Y; Yan S; Liu X; Zhang W; Li Y; Dong R; Zhang Q; Yang Q; Yuan C; Shen K; Kong B Oncol Rep; 2014 Apr; 31(4):1905-10. PubMed ID: 24573236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]